AMERICAN INTERNATIONAL GROUP, INC. - BLUEPRINT MEDICINES CORP ownership

BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 216 filers reported holding BLUEPRINT MEDICINES CORP in Q3 2023. The put-call ratio across all filers is 2.45 and the average weighting 0.2%.

Quarter-by-quarter ownership
AMERICAN INTERNATIONAL GROUP, INC. ownership history of BLUEPRINT MEDICINES CORP
ValueSharesWeighting
Q3 2023$1,524,227
-17.6%
30,351
+3.7%
0.01%
-9.1%
Q2 2023$1,849,927
+42.6%
29,271
+1.5%
0.01%
+22.2%
Q1 2023$1,297,512
+4.8%
28,840
+2.0%
0.01%0.0%
Q4 2022$1,238,333
-33.7%
28,266
-0.4%
0.01%
-35.7%
Q3 2022$1,869,000
+32.3%
28,369
+1.4%
0.01%
+40.0%
Q2 2022$1,413,000
-23.9%
27,968
-3.7%
0.01%0.0%
Q1 2022$1,856,000
-44.3%
29,051
-6.6%
0.01%
-41.2%
Q4 2021$3,331,000
+1.2%
31,096
-2.9%
0.02%
-5.6%
Q3 2021$3,293,000
+14.2%
32,027
-2.3%
0.02%
+80.0%
Q2 2021$2,884,000
-15.5%
32,788
-6.5%
0.01%
-16.7%
Q1 2021$3,411,000
-14.0%
35,082
-0.8%
0.01%
-20.0%
Q4 2020$3,967,000
+29.3%
35,373
+6.9%
0.02%0.0%
Q3 2020$3,068,000
+18.5%
33,091
-0.3%
0.02%
+25.0%
Q2 2020$2,588,000
+39.6%
33,180
+4.7%
0.01%
+20.0%
Q1 2020$1,854,000
-24.3%
31,696
+3.7%
0.01%
+11.1%
Q4 2019$2,450,000
+8.1%
30,579
-0.8%
0.01%0.0%
Q3 2019$2,266,000
-22.6%
30,837
-0.7%
0.01%
-18.2%
Q2 2019$2,929,000
+38.7%
31,051
+17.8%
0.01%
+37.5%
Q1 2019$2,111,000
+43.8%
26,367
-3.1%
0.01%
+33.3%
Q4 2018$1,468,000
-31.4%
27,222
-0.8%
0.01%
-14.3%
Q3 2018$2,141,000
+25.2%
27,432
+1.8%
0.01%
+16.7%
Q2 2018$1,710,000
-31.4%
26,937
-0.9%
0.01%
-33.3%
Q1 2018$2,493,000
+15.4%
27,189
-5.1%
0.01%
+28.6%
Q4 2017$2,161,000
+19.1%
28,651
+10.0%
0.01%
+16.7%
Q3 2017$1,814,000
+48.6%
26,043
+8.1%
0.01%
+50.0%
Q2 2017$1,221,000
+107.3%
24,096
+63.6%
0.00%
+100.0%
Q1 2017$589,000
+82.4%
14,728
+28.0%
0.00%
+100.0%
Q4 2016$323,000
-99.9%
11,507
-0.3%
0.00%0.0%
Q3 2016$342,649,000
+46.9%
11,537
+0.1%
0.00%0.0%
Q2 2016$233,280,000
+135.6%
11,520
+110.0%
0.00%
Q1 2016$99,000,000
-31.7%
5,4860.0%0.00%
-100.0%
Q4 2015$145,000,000
+123831.6%
5,486
-0.2%
0.00%0.0%
Q3 2015$117,000
-99.9%
5,496
+0.1%
0.00%0.0%
Q2 2015$145,430,0005,4900.00%
Other shareholders
BLUEPRINT MEDICINES CORP shareholders Q3 2023
NameSharesValueWeighting ↓
Aquilo Capital Management, LLC 645,539$69,144,0007.84%
DAFNA Capital Management LLC 206,911$22,162,0005.57%
Eagle Health Investments LP 192,639$20,634,0005.03%
Casdin Capital, LLC 1,550,000$166,021,0004.68%
CADIAN CAPITAL MANAGEMENT, LP 450,657$48,270,0002.65%
Avidity Partners Management LP 995,000$106,574,0002.26%
Integral Health Asset Management, LLC 75,000$8,033,0002.22%
Rock Springs Capital Management LP 859,755$92,088,0002.13%
Boxer Capital, LLC 507,374$54,345,0002.11%
EFG Asset Management (North America) Corp. 112,715$12,082,0001.58%
View complete list of BLUEPRINT MEDICINES CORP shareholders